1. A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod. Issue 2 (3rd April 2023) Authors: Roussakis, Andreas-Antonios; Gennaro, Marta; Gordon, Mark Forrest; Reilmann, Ralf; Borowsky, Beth; Rynkowski, Gail; Lao-Kaim, Nicholas P; Papoutsou, Zoe; Savola, Juha-Matti; Hayden, Michael R; Owen, David R; Kalk, Nicola; Lingford-Hughes, Anne; Gunn, Roger N; Searle, Graham; Tabrizi, Sarah J; Pic... Journal: Brain communications Issue: Volume 5:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease. (September 2018) Authors: Reilmann, Ralf; Gordon, Mark Forrest; Anderson, Karen E; Feigin, Andrew; Tabrizi, Sarah J; Leavitt, Blair R; Stout, Julie C; Piccini, Paola; Rynkowski, Gail; Volkinshtein, Rita; Savola, Juha Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗